The role of cytoskeletal proteins in cardiomyopathies.

Cardiomyopathies are serious heart muscle disorders in children and adults, which result in morbidity and premature death. These disorders include hypertrophic cardiomyopathy, dilated cardiomyopathy and restrictive cardiomyopathy. Recently, mutations in seven genes, all encoding sarcomeric proteins, have been identified as causes of familial hypertrophic cardiomyopathy. The genes include those encoding the beta-myosin heavy chain, alpha-tropomyosin, cardiac troponin T, myosin binding protein-C, myosin essential light chain, myosin regulatory light chain, and troponin I. Advances in the understanding of dilated cardiomyopathy have been made recently as well and it appears as if cytoskeletal proteins play a central role. Dystrophin has been identified as the gene responsible for X-linked dilated cardiomyopathy and this protein, which is also responsible for Duchenne and Becker muscular dystrophy, plays an important role in myocyte and cardiomyocyte function. Mutations in other cytoskeletal proteins such as metavinculin, alpha-dystroglycan, alpha- and gamma-sarcoglycan, and muscle LIM protein have also been found to result in dilated cardiomyopathy, suggesting that cytoskeletal proteins play a central role in cardiac function.

[1]  K. Campbell,et al.  A 5' dystrophin duplication mutation causes membrane deficiency of alpha-dystroglycan in a family with X-linked cardiomyopathy. , 1997, Journal of molecular and cellular cardiology.

[2]  J. Seidman,et al.  Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. , 1995, The New England journal of medicine.

[3]  L. Kunkel,et al.  β–sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex , 1995, Nature Genetics.

[4]  Y. Hayashizaki,et al.  Identification of the Syrian hamster cardiomyopathy gene. , 1997, Human molecular genetics.

[5]  E. Hoffman,et al.  HyperCKemic, proximal muscular dystrophies and the dystrophin membrane cytoskeleton, including dystrophinopathies, sarcoglycanopathies, and merosinopathies. , 1996, Current opinion in rheumatology.

[6]  W. McKenna,et al.  Familial dilated cardiomyopathy in the United Kingdom. , 1995, British heart journal.

[7]  Susan C. Brown,et al.  Utrophin-Dystrophin-Deficient Mice as a Model for Duchenne Muscular Dystrophy , 1997, Cell.

[8]  L. Leinwand,et al.  Heterologous expression of a cardiomyopathic myosin that is defective in its actin interaction. , 1994, The Journal of biological chemistry.

[9]  L. Mestroni,et al.  A mutation in the dystrophin gene selectively affecting dystrophin expression in the heart. , 1995, The Journal of clinical investigation.

[10]  F. Muntoni,et al.  Brief report: deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy. , 1993, The New England journal of medicine.

[11]  K. Aldape,et al.  Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy , 1995, Cell.

[12]  Dubowitz,et al.  Transcription of the dystrophin gene in normal tissues and in skeletal muscle of a family with X-linked dilated cardiomyopathy. , 1995, American journal of human genetics.

[13]  Jason T. Su,et al.  Evidence for a dystrophin missense mutation as a cause of X-linked dilated cardiomyopathy. , 1997, Circulation.

[14]  L. Kunkel,et al.  The structural and functional diversity of dystrophin , 1993, Nature Genetics.

[15]  S. Carpenter,et al.  Dystrophin-deficient mdx muscle fibers are preferentially vulnerable to necrosis induced by experimental lengthening contractions , 1990, Journal of the Neurological Sciences.

[16]  D. Ingber,et al.  Mechanotransduction across the cell surface and through the cytoskeleton , 1993 .

[17]  K. Davies,et al.  Dystrobrevin deficiency at the sarcolemma of patients with muscular dystrophy. , 1997, Human molecular genetics.

[18]  J. Ervasti,et al.  Membrane organization of the dystrophin-glycoprotein complex , 1991, Cell.

[19]  K. Campbell,et al.  Brief report: deficiency of a dystrophin-associated glycoprotein (adhalin) in a patient with muscular dystrophy and cardiomyopathy. , 1996, The New England journal of medicine.

[20]  D. Branton,et al.  Sequence similarity of the amino-terminal domain of Drosophila beta spectrin to alpha actinin and dystrophin , 1989, The Journal of cell biology.

[21]  M. Koenig,et al.  Complete cloning of the duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals , 1987, Cell.

[22]  O. Ornatsky,et al.  Immunolocalization of meta-vinculin in human smooth and cardiac muscles , 1988, The Journal of cell biology.

[23]  G. Danieli,et al.  Myocardial involvement is very frequent among patients affected with subclinical Becker's muscular dystrophy. , 1996, Circulation.

[24]  M. Matsuzaki,et al.  Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy , 1997, Nature Genetics.

[25]  Frederick J. Schoen,et al.  A Mouse Model of Familial Hypertrophic Cardiomyopathy , 1996, Science.

[26]  B. Lowes,et al.  Dilated cardiomyopathy associated with deficiency of the cytoskeletal protein metavinculin. , 1996, Circulation.

[27]  L. Kunkel,et al.  Deficiency of adhalin in a patient with muscular dystrophy and cardiomyopathy. , 1996, The New England journal of medicine.

[28]  A. Simcox,et al.  Impairment of muscle function caused by mutations of phosphorylation sites in myosin regulatory light chain , 1995, Nature.

[29]  R. Bonow,et al.  Hypertrophic cardiomyopathy. , 1987, Disease-a-month : DM.

[30]  K. Ohlendieck,et al.  Towards an understanding of the dystrophin-glycoprotein complex: linkage between the extracellular matrix and the membrane cytoskeleton in muscle fibers. , 1996, European journal of cell biology.

[31]  Roger R. Markwald,et al.  Developmental mechanisms of heart disease , 1995 .

[32]  H. Jockusch,et al.  Decreased osmotic stability of dystrophin-less muscle cells from the mdx mouse , 1991, Nature.

[33]  E. Homsher,et al.  Altered cardiac troponin T in vitro function in the presence of a mutation implicated in familial hypertrophic cardiomyopathy. , 1996, The Journal of clinical investigation.

[34]  L. Kunkel,et al.  Mutations That Disrupt the Carboxyl-Terminus of γ-Sarcoglycan Cause Muscular Dystrophy , 1996 .

[35]  L. Kunkel,et al.  Mild and severe muscular dystrophy caused by a single gamma-sarcoglycan mutation. , 1996, American journal of human genetics.

[36]  F. Reinach,et al.  The troponin complex and regulation of muscle contraction , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[37]  K. Campbell,et al.  Association of dystrophin and an integral membrane glycoprotein , 1989, Nature.

[38]  N. Yanagisawa,et al.  Molecular analysis of the duchenne muscular dystrophy gene in patients with becker muscular dystrophy presenting with dilated cardiomyopathy , 1993, Muscle & nerve.

[39]  I. Rayment,et al.  Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle , 1996, Nature Genetics.

[40]  E. Hoffman,et al.  Mutations in the sarcoglycan genes in patients with myopathy. , 1997, The New England journal of medicine.

[41]  L. Mestroni,et al.  A point mutation in the 5' splice site of the dystrophin gene first intron responsible for X-linked dilated cardiomyopathy. , 1996, Human molecular genetics.

[42]  J. Towbin,et al.  X‐Linked Dilated Cardiomyopathy Molecular Genetic Evidence of Linkage to the Duchenne Muscular Dystrophy (Dystrophin) Gene at the Xp21 Locus , 1993, Circulation.

[43]  L. Kunkel,et al.  Detailed analysis of the repeat domain of dystrophin reveals four potential hinge segments that may confer flexibility. , 1990, The Journal of biological chemistry.

[44]  L. Fananapazir,et al.  Abnormal contractile properties of muscle fibers expressing beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy. , 1995, The Journal of clinical investigation.

[45]  J. Ervasti,et al.  A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin , 1993, The Journal of cell biology.

[46]  J. Towbin.  Molecular genetic aspects of cardiomyopathy. , 1993, Biochemical medicine and metabolic biology.

[47]  L. Kunkel,et al.  Dystrophin and Its Isoforms , 1996, Brain pathology.

[48]  J. Small,et al.  An additional exon in the human vinculin gene specifically encodes meta-vinculin-specific difference peptide. Cross-species comparison reveals variable and conserved motifs in the meta-vinculin insert. , 1992, European journal of biochemistry.

[49]  M. Lisanti,et al.  Expression of Caveolin-3 in Skeletal, Cardiac, and Smooth Muscle Cells , 1996, The Journal of Biological Chemistry.

[50]  H. Dietz,et al.  Molecular biology--to the heart of the matter. , 1994, New England Journal of Medicine.

[51]  J. Beckmann,et al.  β–sarcoglycan: characterization and role in limb–girdle muscular dystrophy linked to 4q12 , 1995, Nature Genetics.

[52]  K. Campbell,et al.  Mild congenital muscular dystrophy in two patients with an internally deleted laminin alpha2-chain. , 1997, Human molecular genetics.

[53]  J. Seidman,et al.  Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. , 1992, The New England journal of medicine.

[54]  M. Gautel,et al.  Phosphorylation switches specific for the cardiac isoform of myosin binding protein‐C: a modulator of cardiac contraction? , 1995, The EMBO journal.

[55]  H. Sweeney,et al.  Dystrophin protects the sarcolemma from stresses developed during muscle contraction. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[56]  J. Beckmann,et al.  Advances in the molecular genetics of the limb‐girdle type of autosomal recessive progressive muscular dystrophy , 1996, Current opinion in neurology.

[57]  Z. Kam,et al.  The involvement of adherens junction components in myofibrillogenesis in cultured cardiac myocytes. , 1992, Development.

[58]  A. Monaco,et al.  The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein , 1988, Cell.

[59]  J. Towbin,et al.  Molecular genetics of long QT syndrome from genes to patients. , 1997, Current opinion in cardiology.

[60]  J. Towbin,et al.  Gene mapping of familial autosomal dominant dilated cardiomyopathy to chromosome 10q21-23. , 1996, The Journal of clinical investigation.

[61]  Minoru Hongo,et al.  MLP-Deficient Mice Exhibit a Disruption of Cardiac Cytoarchitectural Organization, Dilated Cardiomyopathy, and Heart Failure , 1997, Cell.

[62]  J. Sanes,et al.  Skeletal and Cardiac Myopathies in Mice Lacking Utrophin and Dystrophin: A Model for Duchenne Muscular Dystrophy , 1997, Cell.

[63]  J. Ervasti,et al.  Dystrophin-glycoprotein complex and laminin colocalize to the sarcolemma and transverse tubules of cardiac muscle. , 1993, Circulation research.

[64]  S. Donnelly,et al.  Familial Hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome maps to a locus on chromosome 7q3. , 1994, The Journal of clinical investigation.

[65]  L. Kunkel,et al.  Dystrophies and heart disease. , 1997, Current opinion in cardiology.